Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises SEB, Handelsbanken and Nordea in connection with Trelleborg’s new issue
Mandate

Vinge advises SEB, Handelsbanken and Nordea in connection with Trelleborg’s new issue

March 23, 2009

Vinge has advised SEB, Handelsbanken and Nordea in connection with Trelleborg AB’s new issue of shares subject to pre-emption rights for the existing shareholders of approximately SEK 2.2 billion. Trelleborg is listed on NASDAQ OMX Stockholm. The issue is underwritten in its entirety by Trelleborg’s major shareholders, certain other interested parties and SEB, Handelsbanken, Nordea and DnB NOR. SEB, Handelsbanken, Nordea and DnB NOR have undertaken to underwrite approximately SEK 900 million which thus comprises approximately 40 per cent of the new issue. The detailed terms and conditions governing the new issue including the subscription price will be determined and communicated on 21 April 2009.

Ola Sandersson and Dain Nevonen advised SEB, Handelsbanken and Nordea.

Related

Vinge has advised Oncopeptides in connection with its rights issue

 Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

 Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025